NYMOX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess ...
January 19 2015 - 10:00PM
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former
Attorney General of Louisiana, Charles C. Foti, Jr., remind
investors that they have until
January 26, 2015 to
file lead plaintiff applications in a securities class action
lawsuit against Nymox Pharmaceutical Corporation (Nasdaq:NYMX) if
they purchased the Company's securities between January 31, 2011
and November 2, 2014, inclusive (the "Class Period"). This action
is pending in the United States District Court for the District of
New Jersey.
What You May Do
If you purchased shares of Nymox and would like to discuss your
legal rights and how this case might affect you and your right to
recover for your economic loss, you may, without obligation or cost
to you, call toll-free at 1-877-515-1850 or email KSF Managing
Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to
serve as a lead plaintiff in this class action, you must petition
the Court by January 26, 2015.
About the Lawsuit
Nymox and certain of its executives are charged with failing to
disclose material information during the Class Period, violating
federal securities laws.
On November 2, 2014, Nymox disclosed that the Company's two
Phase 3 clinical trials for its proprietary drug NX-1207 for the
treatment of benign prostatic hyperplastic (BPH) had to be halted
because the drug failed to meet its primary endpoints for efficacy.
The following day, Nymox disclosed to the market for the first
time, among other things, the difficulties faced in enrolling men
for the trials, and the subjective nature of the measurement of the
drug's success.
On this news, the price of Nymox's stock plummeted by over
80%.
About Kahn Swick & Foti, LLC
To learn more about KSF, whose partners include the Former
Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers
with significant experience litigating complex securities class
actions nationwide on behalf of both institutional and individual
shareholders, you may visit www.ksfcounsel.com.
CONTACT: Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
206 Covington St.
Madisonville, LA 70447
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Mar 2023 to Mar 2024